OTCQX:MRVFF - Post by User
Comment by
HippygirL74on Feb 12, 2010 9:24am
454 Views
Post# 16779378
RE: Why such a focus
RE: Why such a focusIf the stock can be taken down to
.15 by debenture holders and shorters, then do as they do and buy it up. With about
.11 cents cash per share, the
.04 for future Pennsaid revenues and Pennsaid Plus would be a strong buy. But i seriouly doubt we will get to
.15 per share.
Now here is a potential big bonus for us: If the dermal animal studies are positive we will have an advantage over Volteren gel. So if there is no risk of skin cancer and no dangers in Pennsaid when used with sun screen, we will have a larger customer base. Otherwise, cover up with capris and pants. Two year studies started a while ago. This might be a great catalyst for the sp.